Literature DB >> 32146710

Prevalence and Detection of Sexually Transmitted Cases of Laryngeal Carcinoma.

Mohammad Abdulhameed Al-Qudah1, Ala'a Fuad Al-Shaikh2, Husam Kamel Haddad3, Mohammad Abdelatif Elhassan3, Osman Basheir Elhassan3, Melad Nabeel Dababneh3, Anas Wasef Zaitoun4, Nawwaf Saleh Al Ghamdi4, Bara'a Yousef Al-Najjar4.   

Abstract

INTRODUCTION: Human papillomavirus (HPV) is among the reported etiologies of laryngeal squamous cell carcinoma (LSCC). Understanding the impact of HPV on LSCC may help reduce its incidence. This study investigates the association between HPV and LSCC as well as the roles for different immunohistochemical stains in HPV detection.
METHODS: A total of fifty-two formalin-fixed, paraffin-embedded tissue samples of LSCC, diagnosed between 2005 and 2015, were obtained from the archives of the Pathology Department. The samples were stained and processed to evaluate the relationship of HPV to LSCC.
RESULTS: Patients had a mean age of 65.02 ± 14.341 years. By polymerase chain reaction (PCR), high-risk strains of HPV were detected in 15.4% of tissue samples. HPV-16 was found in 75% of the positive samples for an overall prevalence of 13.5%. P16 immunostaining was positive in 15.4% of cases while cyclin B and cyclin E were positive in 65.4% and 76.9%, respectively. Over half of the cases were histologically graded as moderately-differentiated, 28.8% as well-differentiated, and 15.4% as poorly-differentiated. DISCUSSION: The prevalence of HPV-positive LSCC was lower than previously stated in the literature. HPV-16 was the most commonly detected subtype, in concordance with the findings of multiple other studies. HPV-positive LSCC trended with higher histologic grade. P16 and cyclin E immunohistochemical stains were of limited use in identifying HPV in LSCC. In contrast, cyclin B had a high sensitivity which could be used to rule out HPV in LSCC.

Entities:  

Keywords:  Cyclin B; Cyclin E; Cyclin-dependent kinase inhibitor p16; Human papilloma virus; Laryngeal squamous cell carcinoma; PCR

Year:  2020        PMID: 32146710      PMCID: PMC7669925          DOI: 10.1007/s12105-020-01150-2

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  29 in total

1.  Laryngeal cancer and human papillomavirus: HPV is absent in the majority of laryngeal carcinomas.

Authors:  H Lindeberg; A Krogdahl
Journal:  Cancer Lett       Date:  1999-11-01       Impact factor: 8.679

Review 2.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

Review 3.  Cyclin E in normal and neoplastic cell cycles.

Authors:  Harry C Hwang; Bruce E Clurman
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

4.  Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma.

Authors:  Youyi Dong; Li Sui; Yasuo Watanabe; Katsuyoshi Sugimoto; Masaaki Tokuda
Journal:  Cancer Lett       Date:  2002-03-08       Impact factor: 8.679

5.  Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.

Authors:  Khaled A Hassan; K Kian Ang; Adel K El-Naggar; Michael D Story; Janet I Lee; Diane Liu; Waun K Hong; Li Mao
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Detection of human papillomavirus DNA in laryngeal squamous cell carcinoma by polymerase chain reaction.

Authors:  G Almadori; G Cadoni; P Cattani; P Posteraro; E Scarano; F Ottaviani; G Paludetti; M Maurizi
Journal:  Eur J Cancer       Date:  1996-05       Impact factor: 9.162

Review 7.  Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis.

Authors:  M A O'Rorke; M V Ellison; L J Murray; M Moran; J James; L A Anderson
Journal:  Oral Oncol       Date:  2012-07-28       Impact factor: 5.337

8.  Comparison of Polymerase Chain Reaction and Immunohistochemistry Assays for Analysing Human Papillomavirus Infection in Oral Squamous Cell Carcinoma.

Authors:  Muhammad Sohail Awan; Babar Irfan; Ibrahim Zahid; Yumna Mirza; Syed Adnan Ali
Journal:  J Clin Diagn Res       Date:  2017-06-01

9.  Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.

Authors:  Michelle M Rietbergen; Peter J F Snijders; Derakshan Beekzada; Boudewijn J M Braakhuis; Arjen Brink; Daniëlle A M Heideman; Albertus T Hesselink; Birgit I Witte; Elisabeth Bloemena; Robert J Baatenburg-De Jong; C René Leemans; Ruud H Brakenhoff
Journal:  Int J Cancer       Date:  2013-11-19       Impact factor: 7.396

10.  Human papillomavirus infection in patients with laryngeal carcinoma.

Authors:  Ozlem Onerci Celebi; Ebru Sener; Sefik Hosal; Mustafa Cengiz; Ibrahim Gullu; Gaye Guler Tezel
Journal:  BMC Cancer       Date:  2018-10-20       Impact factor: 4.430

View more
  1 in total

1.  The association between lncRNA H19 and EZH2 expression in patients with EBV-positive laryngeal carcinoma.

Authors:  Irina E Hotoboc; Alina Fudulu; Raluca Grigore; Serban Bertesteanu; Irina Huica; Iulia V Iancu; Anca Botezatu; Coralia Bleotu; Gabriela Anton
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-11-26       Impact factor: 2.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.